BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lippi G, Sanchis-Gomar F. Procalcitonin in inflammatory bowel disease: Drawbacks and opportunities. World J Gastroenterol 2017; 23(47): 8283-8290 [PMID: 29307988 DOI: 10.3748/wjg.v23.i47.8283] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Zhang B, Gan L, Shahid MS, Lv Z, Fan H, Liu D, Guo Y. In vivo and in vitro protective effect of arginine against intestinal inflammatory response induced by Clostridium perfringens in broiler chickens. J Anim Sci Biotechnol 2019;10:73. [PMID: 31428367 DOI: 10.1186/s40104-019-0371-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
2 Li T, Li X, Liu X, Zhu Z, Zhang M, Xu Z, Wei Y, Feng Y, Qiao X, Yang J, Dong G. Association of Procalcitonin to Albumin Ratio with the Presence and Severity of Sepsis in Neonates. JIR 2022;Volume 15:2313-21. [DOI: 10.2147/jir.s358067] [Reference Citation Analysis]
3 Xu HG, Tian M, Pan SY. Clinical utility of procalcitonin and its association with pathogenic microorganisms. Crit Rev Clin Lab Sci 2021;:1-19. [PMID: 34663176 DOI: 10.1080/10408363.2021.1988047] [Reference Citation Analysis]
4 Lippi G, Cervellin G. Procalcitonin for diagnosing and monitoring bacterial infections: for or against? Clinical Chemistry and Laboratory Medicine (CCLM) 2018;56:1193-5. [DOI: 10.1515/cclm-2018-0312] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
5 Mishra S, Ram S, Prasad KK, Sharma AK, Dutta U, Sharma V. SERUM PROCALCITONIN AS A PROGNOSTIC MARKER IN ACUTE SEVERE ULCERATIVE COLITIS: A PROSPECTIVE STUDY. Arq Gastroenterol 2022;59:75-9. [DOI: 10.1590/s0004-2803.202200001-14] [Reference Citation Analysis]
6 Montagnana M, Danese E, Lippi G. Biochemical markers of acute intestinal ischemia: possibilities and limitations. Ann Transl Med. 2018;6:341. [PMID: 30306080 DOI: 10.21037/atm.2018.07.22] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
7 Duan S, Gu X, Fan G, Zhou F, Zhu G, Cao B. C-reactive protein or procalcitonin combined with rhinorrhea for discrimination of viral from bacterial infections in hospitalized adults in non-intensive care units with lower respiratory tract infections. BMC Pulm Med 2021;21:308. [PMID: 34583675 DOI: 10.1186/s12890-021-01672-7] [Reference Citation Analysis]
8 Gai L, Chu L, Xia R, Chen Q, Sun X. Barbaloin Attenuates Mucosal Damage in Experimental Models of Rat Colitis by Regulating Inflammation and the AMPK Signaling Pathway. Med Sci Monit 2019;25:10045-56. [PMID: 31881016 DOI: 10.12659/MSM.918935] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
9 Abdehagh M, Azimirad M, Houri H, Nadalian B, Azimirad F, Olfatifar M, Nasir Shoeibi OK, Yadegar A, Shahrokh S, Mahdavi Roshan M, Asadzadeh Aghdaei H, Zali MR. Serum procalcitonin levels associate with Clostridioides difficile infection in patients with inflammatory bowel disease. BMC Infect Dis 2021;21:1103. [PMID: 34702217 DOI: 10.1186/s12879-021-06804-2] [Reference Citation Analysis]